Refractory epilepsy: one size does not fit all
- PMID: 17260051
- PMCID: PMC1783491
- DOI: 10.1111/j.1535-7511.2006.00137.x
Refractory epilepsy: one size does not fit all
Abstract
A unifying definition of refractory epilepsy has been hotly debated but, to date, has not been agreed upon. Evidence from clinical trials indicates that some patients actually are not refractory, as many will partially respond to add-on treatment or will worsen when antiepileptic drugs (AEDs) are removed. There are several important issues relating to the assessment of AED response that routinely have not been addressed in the determination of treatment responsiveness, such as incorporating baseline seizure severity, including partial response rather than solely an all-or-none response, and the consideration of variability in response over time.
Similar articles
-
Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.Epilepsia. 2012 Apr;53(4):733-40. doi: 10.1111/j.1528-1167.2012.03416.x. Epub 2012 Feb 23. Epilepsia. 2012. PMID: 22360822
-
Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.Epilepsy Behav. 2017 Apr;69:59-68. doi: 10.1016/j.yebeh.2016.10.010. Epub 2017 Feb 23. Epilepsy Behav. 2017. PMID: 28235655
-
Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?Epilepsy Behav. 2014 Feb;31:73-6. doi: 10.1016/j.yebeh.2013.11.016. Epub 2013 Dec 20. Epilepsy Behav. 2014. PMID: 24361766
-
Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.Epilepsy Res. 2018 Jul;143:120-129. doi: 10.1016/j.eplepsyres.2017.10.004. Epilepsy Res. 2018. PMID: 29784458
-
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy.Neurology. 2003 Jun 10;60(11 Suppl 4):S2-12. doi: 10.1212/wnl.60.11_suppl_4.s2. Neurology. 2003. PMID: 12796516 Review.
Cited by
-
'On-demand' gene therapy for epilepsy.Nat Rev Neurol. 2023 Mar;19(3):130-131. doi: 10.1038/s41582-022-00761-3. Nat Rev Neurol. 2023. PMID: 36509840 No abstract available.
-
Subpial transection surgery for epilepsy.Cochrane Database Syst Rev. 2018 Nov 1;11(11):CD008153. doi: 10.1002/14651858.CD008153.pub4. Cochrane Database Syst Rev. 2018. PMID: 30383287 Free PMC article.
-
Felbamate add-on therapy for drug-resistant focal epilepsy.Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008295. doi: 10.1002/14651858.CD008295.pub6. Cochrane Database Syst Rev. 2022. PMID: 35914010 Free PMC article.
-
Refractory headache: one term does not cover all--a statement of the European Headache Federation.J Headache Pain. 2014 Aug 28;15(1):50. doi: 10.1186/1129-2377-15-50. J Headache Pain. 2014. PMID: 25169963 Free PMC article. No abstract available.
-
A pH-sensitive closed-loop nanomachine to control hyperexcitability at the single neuron level.Nat Commun. 2024 Jul 4;15(1):5609. doi: 10.1038/s41467-024-49941-3. Nat Commun. 2024. PMID: 38965228 Free PMC article.
References
-
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–319. - PubMed
-
- Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 1979;20:729–737. - PubMed
-
- Mattson RH, Cramer JA, Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology. 1996;47:68–76. - PubMed
-
- Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. Early development of intractable epilepsy in children: A prospective study. Neurology. 2001;56:1445–1452. - PubMed
-
- Dlugos DJ, Sammel MD, Strom BL, Farrar JT. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology. 2001;57:2259–2264. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources